Literature DB >> 15716521

The neuropsychology of variant CJD: a comparative study with inherited and sporadic forms of prion disease.

R J Cordery1, K Alner, L Cipolotti, M Ron, A Kennedy, J Collinge, M N Rossor.   

Abstract

OBJECTIVE: To assess cognitive function in variant Creutzfeldt-Jakob disease (vCJD). We describe the neuropsychological profiles of 10 cases and compare these data with cross sectional data obtained from patients with histologically confirmed sporadic CJD and cases with inherited prion disease with confirmed mutations in the prion protein gene.
METHODS: Patients referred to the Specialist Cognitive Disorders Clinic at the National Hospital for Neurology and Neurosurgery and the National Prion Clinic at St Mary's Hospital, London for further investigation of suspected CJD were recruited into the study. The neuropsychological test battery evaluated general intelligence, visual and verbal memory, nominal skills, literacy skills, visual perception and visuospatial functions, and visuospatial and executive function.
RESULTS: The results indicate that moderate to severe cognitive decline is a characteristic feature of vCJD. Specifically, verbal and visual memory impairments and executive dysfunction were pervasive in all disease groups. Nominal skills were impaired in variant and sporadic CJD, significantly so when compared with the inherited prion disease group. Perceptual impairment was less frequent in the vCJD group than in the sporadic and inherited groups.
CONCLUSION: This study confirms the occurrence of generalised cognitive decline in patients with vCJD. Although decline in cognitive function ultimately affects all domains, there is a suggestion that some components of visual perception may be spared in vCJD. The results also suggest that nominal function may be preserved in some cases with inherited prion disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15716521      PMCID: PMC1739530          DOI: 10.1136/jnnp.2003.030320

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  29 in total

1.  Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features.

Authors:  J Collinge; J Brown; J Hardy; M Mullan; M N Rossor; H Baker; T J Crow; R Lofthouse; M Poulter; R Ridley
Journal:  Brain       Date:  1992-06       Impact factor: 13.501

2.  New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests.

Authors:  M Zeidler; G E Stewart; C R Barraclough; D E Bateman; D Bates; D J Burn; A C Colchester; W Durward; N A Fletcher; S A Hawkins; J M Mackenzie; R G Will
Journal:  Lancet       Date:  1997-09-27       Impact factor: 79.321

3.  Florid plaques and new variant Creutzfeldt-Jakob disease.

Authors:  J W Ironside; J E Bell
Journal:  Lancet       Date:  1997-11-15       Impact factor: 79.321

4.  Fatal familial insomnia: behavioral and cognitive features.

Authors:  R Gallassi; A Morreale; P Montagna; P Cortelli; P Avoni; R Castellani; P Gambetti; E Lugaresi
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

5.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.

Authors:  J Collinge; K C Sidle; J Meads; J Ironside; A F Hill
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

6.  Sporadic Creutzfeldt-Jakob disease in a 18-year-old in the UK.

Authors:  D Bateman; D Hilton; S Love; M Zeidler; J Beck; J Collinge
Journal:  Lancet       Date:  1995-10-28       Impact factor: 79.321

7.  Creutzfeldt-Jakob disease in a young woman.

Authors: 
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

8.  Thalamic form of Creutzfeldt-Jakob disease or fatal insomnia? Report of a sporadic case with normal prion protein genotype.

Authors:  K Kawasaki; K Wakabayashi; A Kawakami; M Higuchi; T Kitamoto; S Tsuji; H Takahashi
Journal:  Acta Neuropathol       Date:  1997-03       Impact factor: 17.088

9.  Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent.

Authors:  M E Bruce; R G Will; J W Ironside; I McConnell; D Drummond; A Suttie; L McCardle; A Chree; J Hope; C Birkett; S Cousens; H Fraser; C J Bostock
Journal:  Nature       Date:  1997-10-02       Impact factor: 49.962

10.  Creutzfeldt-Jakob disease after administration of human growth hormone.

Authors:  J Powell-Jackson; R O Weller; P Kennedy; M A Preece; E M Whitcombe; J Newsom-Davis
Journal:  Lancet       Date:  1985-08-03       Impact factor: 79.321

View more
  5 in total

1.  The cognitive phenotypes of Creutzfeldt-Jakob disease: comparison with secondary metabolic encephalopathy.

Authors:  Anna Rita Giovagnoli; Giuseppe Di Fede; Giacomina Rossi; Fabio Moda; Marina Grisoli; Orso Bugiani
Journal:  Neurol Sci       Date:  2022-01-28       Impact factor: 3.307

2.  Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease.

Authors:  B Meissner; K Kallenberg; P Sanchez-Juan; A Krasnianski; U Heinemann; D Varges; M Knauth; I Zerr
Journal:  AJNR Am J Neuroradiol       Date:  2008-07-03       Impact factor: 3.825

3.  The cognitive profile of prion disease: a prospective clinical and imaging study.

Authors:  Diana Caine; Renata J Tinelli; Harpreet Hyare; Enrico De Vita; Jessica Lowe; Ana Lukic; Andrew Thompson; Marie-Claire Porter; Lisa Cipolotti; Peter Rudge; John Collinge; Simon Mead
Journal:  Ann Clin Transl Neurol       Date:  2015-04-07       Impact factor: 4.511

4.  Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation.

Authors:  Laura Eisenmenger; Marie-Claire Porter; Christopher J Carswell; Andrew Thompson; Simon Mead; Peter Rudge; John Collinge; Sebastian Brandner; Hans R Jäger; Harpreet Hyare
Journal:  JAMA Neurol       Date:  2016-01       Impact factor: 18.302

5.  Multiparameter MR imaging in the 6-OPRI variant of inherited prion disease.

Authors:  E De Vita; G R Ridgway; R I Scahill; D Caine; P Rudge; T A Yousry; S Mead; J Collinge; H R Jäger; J S Thornton; H Hyare
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-28       Impact factor: 3.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.